Annual Drug Patent Expirations for LANSOPRAZOLE Lansoprazole is a drug marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Breckenridge, Dr Reddys Labs Ltd, Hetero Labs Ltd Iii, Inventia, Krka Tovarna…
The post New patent for Dexcel Pharma drug LANSOPRAZOLE…
This chart shows the pharmaceutical companies with the most patents in Finland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Finland? Read Post »
Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fourteen…
The post New patent expiration for Boehringer Ingelhe…
New patent expiration for Boehringer Ingelheim drug STRIVERDI RESPIMAT Read Post »
Annual Drug Patent Expirations for COMBIVENT+RESPIMAT Combivent Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven…
The post New patent expiration for Boehringer Ingelheim …
New patent expiration for Boehringer Ingelheim drug COMBIVENT RESPIMAT Read Post »
This chart shows the drugs with the most patents in Israel. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Israel? …
Which pharmaceutical drugs have the most drug patents in Israel? Read Post »
Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fourteen…
The post New patent expiration for Boehringer Ingelheim d…
New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT Read Post »
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent expiration for Glaxosmithkline drug …
New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Glaxo Grp drug BREO ELLIPTA appeared first on…
New patent expiration for Glaxo Grp drug BREO ELLIPTA Read Post »
Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Gla…
New patent expiration for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF Read Post »
Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Glaxosmithkline drug ARN…
New patent expiration for Glaxosmithkline drug ARNUITY ELLIPTA Read Post »
Get new actionable insights and updates from BiotechBlog
